Many British surgeons with new product procedure ideas they would like to see commercialised, believe only one in ten will actually reach the market in the next few years. Asurvey of surgeons was carried out by medical solutions firm Xiros at this year’s British Orthopaedic Association’s annual congress, launch pad for the firm’s £2 m R&D investment fund, designed to speed ideas to market.
Many obstacles were cited in support of this pessimism, including funding, development resources and regulatory conditions pointing to the fact that access to resources and knowledge beyond the clinical environment is key in reaching the market.
David Beevers, Xiros innovations director, said: “There is no doubt front line surgical experience is a key source of surgical innovation and new ideas, but there are consistent key factors in the commercialisation gap. The fund was launched to close the gap and has immediately attracted a number of very promising concepts from contributing surgeons.”
